Ann: Strategic Plan & Asset Review, WoundVue, page-17

Well I did warn you........that the business model does not really stack up despite a product that would be good for productivity.

Somebody screwed up when deciding to make this product in the first place.

Market won't pay a price that is sufficient for a suitable return on invested capital and investors have been too gullible.

Take a look at the valuation on nanosonics or somnomed perhaps......

I really worry when investors start talking up stocks on the basis of Market Cap to REVENUE multiples rather than Price to Earnings multiples..........

It usually ends in tears but not after the rampers have made a killing and the ill informed get taken for a ride.

Beware - everything is not always what it seems!

Did someone suggest LBT was bleeding??????

It is not all BB's fault, he is just doing his best with a product that was developed by others on faulty assumptions about market potential and market pricing.

Better call an ambulance anyway............